Update on the classification and treatment of localized scleroderma;Actualización en la clasificación y el tratamiento de la esclerodermia localizada

Actas Dermo-Sifiliograficas

Volumn 104, Issue 8, 2013, Pages 654-666

  Bielsa Marsol, I ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Atrophoderma of Pasini and Pierini; Deep morphea; Eosinophilic fasciitis; Lichen sclerosus et atrophicus; Morphea en coup de sabre; Progressive facial hemiatrophy

Indexed keywords

CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FIBROSIS; LINEAR SCLERODERMA; LOCALIZED SCLERODERMA; MORBIDITY; MORPHEA; PANSCLEROTIC MORPHEA; PLAQUE MORPHEA; REVIEW; SKIN STRUCTURE;

ATROFODERMIA DE PASINI Y PIERINI; ATROPHODERMA OF PASINI AND PIERINI; DEEP MORPHEA; EOSINOPHILIC FASCIITIS; FASCITIS EOSINOFÍLICA; HEMIATROFIA FACIAL PROGRESIVA; LICHEN SCLEROSUS ET ATROPHICUS; LIQUEN ESCLEROSO Y ATRÓFICO; MORFEA EN COUP DE SABRE; MORFEA PROFUNDA; MORPHEA EN COUP DE SABRE; PROGRESSIVE FACIAL HEMIATROPHY;

ALGORITHMS; AMINOQUINOLINES; CLINICAL TRIALS AS TOPIC; EOSINOPHILIA; FASCIITIS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; PHOTOCHEMOTHERAPY; PHYSICAL THERAPY MODALITIES; RECURRENCE; SCLERODERMA, LOCALIZED; SEVERITY OF ILLNESS INDEX;

EID: 84884553694     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.adengl.2012.10.012     Document Type: Short Survey

References (121)

1. N. Fett, and V.P. Werth Update on morphea. Part I. Epidemiology, clinical presentation, and pathogenesis J Am Acad Dermatol 64 2011 217 228
2. A. Silman, S. Jannini, D. Symmons, and P. Bacon An epidemiological study of scleroderma in the West Midlands Br J Rheumatol 27 1988 286 290
3. L.S. Peterson, A.M. Nelson, W.P. Su, T. Mason, W.M. O'Fallon, and S.E. Gabriel The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993 J Rheumatol 24 1997 73 80
4. A.V. Marzano, S. Menni, A. Parodi, A. Borghi, A. Fuligni, and P. Fabbri Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases Eur J Dermatol 13 2003 171 176
5. F. Zulian, B.H. Athreya, R. Laxer, A.M. Nelson, S.K. Feitosa de Oliveira, and M.G. Punaro Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study Rheumatology (Oxford) 45 2006 614 620
6. J.J. Leitenberger, R.L. Cayce, R.W. Haley, B. Adams-Huet, P.R. Bergstresser, and H.T. Jacobe Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases Arch Dermatol 145 2009 545 550
7. L.S. Peterson, A.M. Nelson, and W.P.D. Su Classification of morphea (localized scleroderma) May Clin Proc 70 1995 1068 1076
8. M.D. Mayes Classification and epidemiology of scleroderma Semin Cutan Med Surg 17 1998 22 26
9. D. Tuffanelli Localized scleroderma Semin Cutan Med Surg 17 1998 27 33
10. C. Salmon-Ehr Eschard, and B. Kalis Morphées: classification et pris en charge Ann Dermatol Venereol 125 1998 283 290
11. E. Vierra, and B.B. Cunningham Morphea and localized scleroderma in children Semin Cut Med Surg 18 1999 210 225
12. A. Hawk, and J.C. English Localized and systemic scleroderma Semin Cutan Med Surg 20 2001 27 37
13. L. Chung, J. Lin, D.E. Furst, and D. Fiorentino Systemic and localized scleroderma Clin Dermatol 24 2006 374 392
14. I. Bielsa, and A. Ariza Deep morphea Semin Cutan Med Surg 26 2007 90 95
15. R. Laxer, and F. Zulian Localized scleroderma Curr Opin Rheumatol 18 2006 606 613
16. D. Kencka, M. Blaszczyk, and S. Jablonska Atrophoderma Pasini-Pierini is a primary atrophic abortive morphea Dermatology 190 1995 203 206
17. S. Jablonska, and M. Blaszczyk Is superficial morphea synonymous with atrophoderma Pasini-Pierini J Am Acad Dermatol 50 2004 979 980
18. J. McNiff, E.J. Glusac, R.Z. Lazova, and C.B. Carroll Morphea limited to the superficial reticular dermis: an underrecognized histologic phenomenon Am J Dermatopathol 21 1999 315 319
19. A. Trattner, M. David, and M. Sandbank Bullous morphea: a distinct entity Am J Dermatopathol 16 1994 414 417
20. M.S. Daoud, W.P. Su, K.M. Leiferman, and C. Perniciaro Bullous morphea: clinical pathologic and immunopathologic evaluation of 13 cases J Am Acad Dermatol 30 1994 937 943
21. A. Rencic, S. Goyal, M. Mofid, F. Wigley, and H.C. Nousari Bullous lesions in scleroderma Int J Dermatol 41 2002 335 339
22. D. Sawamura, T. Yaguchi, I. Hashimoto, K. Nomuka, R. Konta, and K. Umeki Coexistence of generalized morphea with histological changes in lichen sclerosus et atrophicus Int J Dermatol 25 1998 409 411
23. J. Uitto, D.J. Santa Cruz, E.A. Bauer, and A.Z. Eisen Morphea and lichen sclerosus et atrophicus J Am Acad Dermatol 3 1980 271 279
24. S. Shono, M. Imura, M. Ota, A. Osaku, S. Shinomiya, and K. Toda Lichen sclerosus et atrophicus, morphea and coexistence of both diseases: histological studies using lectins Arch Dermatol 127 1991 1352 1356
25. A.M. Farrell, P.M. Marren, and F. Wojnarowska Genital lichen sclerosus associated with morphea or systemic sclerosis: clinical and HLA characteristics Br J Dermatol 143 2000 598 603
26. J.A.K. Patterson, and A.B. Ackerman Lichen sclerosus et atrophicus is not related to morphea Am J Dermatopathol 6 1984 323 335
27. C. Kowalewsky, A. Kozlowsk, M. Gorska, M. Krajewski, M. Blaszczyk, and S. Jablonska Alterations of basement membrane zone and cutaneous microvasculature in morphea and extragenital lichen sclerosus Am J Dermatopathol 27 2005 489 496
28. S.J. Whittaker, N.P. Smith, and R. Jones Solitary morphea profunda Br J Dermatol 120 1989 431 440
29. K.A. Kobayashi, H. Lui, and J.S. Prendiville Solitary morphea profunda in a 5-year-old girl: case report and review of the literature Pediatr Dermatol 8 1991 292 295
30. R.S. Kirsner, J.B. Pardes, and V. Falanga Solitary fibrosing paraspinal plaque: solitary morphea profunda Br J Dermatol 128 1993 99 101
31. J. Azad, G. Dawn, F.C.G. Shaffrali, S.C. Holmes, R.J. Barnetson, and A. Forsyth Does solitary morphea profunda progress Clin Exp Dermatol 29 2004 25 27
32. W.P. Su, and S.L. Greene Bullous morphea profunda Am J Dermatopathol 8 1986 144 147
33. S.K. Ahn, J.H. Won, E.H. Choi, S.C. Kim, and S.H. Lee Perforating plate-like osteoma cutis in a man with solitary morphea profunda Br J Dermatol 134 1996 949 952
34. C.G. Julian, and P.W. Bowers Osteoma cutis in a lesion of solitary morphea profunda Clin Exp Dermatol 28 2003 673 674
35. A. Torrelo, J. Suárez, I. Colmenero, D. Azorín, A. Perera, and A. Zambrano Deep morphea after vaccination in two young children Pediatr Dermatol 23 2006 484 487
36. A. Morell, and I. Betlloch Morphea-like reaction from vitamin K1 Int J Dermatol 34 1995 201 202
37. E. Bourrat, I. Moraillon, M.D. Vignon-Pennamen, S. Fraitag, B. Cavelier-Balloy, and F. Cordoliani Scleroderma-like patch on the thigh in infants after vitamin K injection at birth: six observations Ann Dermatol Venereol 123 1996 634 638
38. R. Fleischmajer, and A. Nedwich Generalized morphea I. Histology of the dermis and subcutaneous tissue Arch Dermatol 106 1972 509 514
39. J.R. Person, and W.P.D. Su Subcutaneous morphea: a clinical study of sixteen cases Br J Dermatol 100 1979 371 380
40. W.P.D. Su, and J.R. Person Morphea profunda. A new concept and a histopathologic study of 23 cases Am J Dermatopathol 3 1981 251 260
41. K. Sayama, M. Chen, S. Shiraishi, and Y. Miki Morphea profunda Int J Dermatol 30 1991 873 875
42. M. Balabanova, and E. Obreshkova Scleroderma profunda. Clinicopathological studies Adv Exp Med Biol 455 1999 105 109
43. J.H. Park, and C.W. Lee Concurrent development of dermatomyositis and morphea profunda Clin Exp Dermatol 27 2002 324 327
44. E.M. Caperton, D.E. Hathaway, and L.P. Dehner Morphea, fasciitis and scleroderma with eosinophilia: a broad spectrum of disease [abstract] Arthritis Rheum 19 1976 792 793
45. D.F. King, D.J. Dore Rk Gilbert, A.W. Gurevitch, and F.M. Hirose Generalized morphea with peripheral eosinophilia: fasciitis and myositis Int J Dermatol 19 1980 149 153
46. I. Bielsa, M. Cid, C. Herrero, and F. Cardellach Generalized morphea: systemic aspects of a cutaneous disease. Description of 12 cases and review of the literature Med Clin (Barc) 85 1985 171 174
47. L. Dehen, J.C. Roujeau, A. Cosnes, and J. Revuz Internal involvement in localized scleroderma Medicine 73 1994 241 245
48. S. Christen-Zaech, M.D. Hakim, F.S. Afsar, and A.S. Paller Pediatric morphea (localized scleroderma): Review of 136 patients J Am Acad Dermatol 59 2008 385 396
49. V. Falanga, T.A. Medsger Jr., and M. Reichlin Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea Arch Dermatol 123 1987 350 353
50. M. Hasegawa, M. Fujimoto, I. Hayakawa, T. Matsushita, C. Nishijima, and M. Yamazaki Anti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma Clin Exp Dermatol 24 2006 19 24
51. S. Sato, M. Fujimoto, H. Ihn, K. Kikuchi, and K. Takehara Antigen specificity of antihistone antibodies in localized scleroderma Arch Dermatol 130 1994 1273 1277
52. S. Sato, M. Fujimoto, H. Ihn, K. Kikuchi, and K. Takehara Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma J Am Acad Dermatol 31 1994 567 571
53. M. Parodi Drosera, L. Barbieri, and A. Rebora Antihistone antibodies in scleroderma Dermatology 191 1995 16 18
54. K. Kikuchi, S. Sato, T. Kadono, H. Ihn, and K. Takehara Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma Arch Dermatol 130 1994 1269 1272
55. M.K. Connolly Systemic sclerosis (scleroderma) and related disorders J.L. Bolognia, J.L. Jorizzo, R.P. Rapini, Dermatology 2008 Elsevier Madrid 585 596
56. L.E. Shulman Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: A new syndrome? [abstract] J Rheumatol 1 Suppl 1 1974 46
57. G.P. Rodnan, A.G. DiBartolomeo, and T.A. Medsger Eosinophilic fasciitis: report of six cases of a newly recognized scleroderma-like syndrome Arthritis Rheum 18 1975 525
58. C.J. Michet Jr., J.A. Doyle, and W.W. Ginsburg Eosinophilic fasciitis: report of 15 cases May Clin Proc 56 1981 27 34
59. S. Lakhanpal, W.W. Ginsburg, C.J. Michet, J.A. Doyle, and S.B. Moore Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases Semin Arthritis Rheum 17 1988 221 231
60. J.J. Miller The fasciitis-morphea complex in children AJDC 146 1992 733 736
61. J. Castanet, C. Lacour Jph Perrin, B. Taillan, D. Dubois, and J.P. Ortonne Association of eosinophilic fasciitis, multiple morphea and antiphospholipid antibody Dermatology 189 1994 304 307
62. N. Heidary, W. Cheung, N. Wang, H. Kamino, and A.G. Franks Jr. Eosinophilic fasciitis/generalized morphea overlap Dermatology Online Journal 15 2009 2 6
63. L. Barnes, G.P. Rodnan, T.A. Medsger Jr., and D. Short Eosinophilic fasciitis. A pathological study of twenty cases Am J Pathol 96 1979 493 518
64. A.J. Griffin Eosinophilic fasciitis with megakaryocyte aplasia J R Soc Med 72 1979 779 781
65. R. Hoffman, N. Dainiak, L. Sibrack, J.S. Pober, and J.A. Waldron Jr. Antibody-mediated aplastic anemia and diffuse fasciitis N Engl J Med 300 1979 718 721
66. G.O. Littlejohn, and E.C. Keystone Eosinophilic fasciitis and aplastic anemia J Rheumatol 7 1980 730 732
67. B. Bonnotte, B. Chauffert, D. Caillot, F. Martin, and B. Lorcerie Successful treatment with antithymocyte globulin and cyclosporine A of a severe aplastic anemia associated with an eosinophilic fasciitis Br J Rheumatol 37 1998 1358 1359
68. V.P. García, J.F. de Quiros, and L. Caminal Autoimmune haemolytic anemia associated with eosinophilic fasciitis J Rheumatol 25 1998 1864 1865
69. H. Masuoka, K. Kikuchi, S. Takahashi, T. Kakinuma, N. Hayashi, and M. Furue Eosinophilic fasciitis associated with low-grade T-cell lymphoma Br J Dermatol 139 1998 928 930
70. J.E. Naschitz, I. Misselevich, I. Rosner, D. Yeshurun, P. Weiner, and M. Amar Lymph-node-based malignant lymphoma and reactive lymphadenopathy in eosinophilic fasciitis Am J Med Sci 318 1999 343 349
71. L. Weibel, and J.I. Harper Linear morphea follows Blaschko's lines Br J Dermatol 159 2008 175 181
72. L. Orozco-Covarrubias, A. Guzman-Meza, C. Ridaura-Sanz, D. Carrasco-Daza, C. Sosa-de-Martinez, and R. Ruiz-Maldonado Scleroderma en coup de sabre and progressive facial hemiatrophy. It is possible to differentiate them? J Eur Acad Dermatol Venereol 16 2002 361 366
73. M. Blaszczyk, L. Krolicki, M. Krasu, O. Glinska, and S. Jablonska Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre J Rheumatol 30 2003 1997 2004
74. M.M. Tollefson, and P.M. Witman En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients J Am Acad Dermatol 56 2007 157 163
75. M.E. Zannin, G. Martini, B.H. Athreya, R. Russo, G. Higgins, and F. Vitadello Ocular involvement in children with localized scleroderma: a multi-centre study Br J Ophthalmol 91 2007 1311 1314
76. J.L. Díaz-Pérez, S.M. Connolly, and R.K. Winkelmann Disabling pansclerotic morphea of children Arch Dermatol 116 1980 169 173
77. S.H. Maragh, M.D. Davis, A.J. Bruce, and A.M. Nelson Disabling pansclerotic morphea: clinical presentation in two adults J Am Acad Dermatol 53 2005 S115 S119
78. C. Ferrándiz, J. Henkes, J. González, and J. Peyrí Incapacitating pansclerotic morphea in childhood Med Cutan Ibero Lat Am 9 1981 377 382
79. P.C. Parodi, C. Riberti, D. Draganic Stinco, P. Patrone, and G. Stinco Squamous cell carcinoma arising in a patient with long-standing pansclerotic morphea Br J Dermatol 144 2001 417 419
80. U. Wollina, M. Buslau, and W. Weyers Squamous cell carcinoma in pansclerotic morphea of childhood Pediatr Dermatol 19 2002 151 154
81. A. Kreuter, P. Altmeyer, and T. Gambichler Treatment of localized scleroderma depends on the clinical subtype Br J Dermatol 156 2007 1363 1365
82. N. Fett, and V.P. Werth Update on morphea: part II. Outcome measures and treatment J Am Acad Dermatol 64 2011 231 242
83. N. Hunzelmann, S. Anders, G. Fierlbeck, R. Hein, K. Herrmann, and M. Albrecht Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma J Am Acad Dermatol 36 1997 433 435
84. M.M. Hulshof, J.N. Bouwes Bavinck, W. Bergman, A.A. Masclee, L. Heickendorff, and F.C. Breedveld Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic sclerosis J Am Acad Dermatol 43 2000 1017 1023
85. M.M.B. Seyger, F.H.J. van den Hoogen, T. de Boo, and E.M.G.J. de Jong Low-dose methotrexate in the treatment of widespread morphea J Am Acad Dermatol 39 1998 220 225
86. A. Kreuter, T. Gambichler, F. Breuckmann, S. Rotterdam, M. Freitag, and M. Stuecker Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma Arch Dermatol 141 2005 847 852
87. Y. Uziel, B.M. Feldman, B.R. Krafchik, R.S. Yeung, and R.M. Laxer Methotrexate and corticosteroids therapy for pediatric localized scleroderma J Pediatr 136 2000 91 95
88. L. Weibel, M.C. Sampaio, M.T. Visentin, K.J. Howell, P. Woo, and J.I. Harper Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphea) in children Br J Dermatol 155 2006 1013 1020
89. P.G. Fitch, P. Rettig, J.M. Burnham, T.H. Finkel, A.C. Yan, and E. Akin Treatment of pediatric localized scleroderma with methotrexate J Rheumatol 33 2006 609 614
90. D. Cox, G. O'Regan, S. Collins, A. Byrne, A. Irvine, and R. Watson Juvenile localized scleroderma: a retrospective review of response to systemic treatment Ir J Med Sci 177 2008 343 346
91. E.B. Kroft, M.C. Creemers, F.H. van den Hoogen, J.B. Boezeman, and E.M. de Jong Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study Br J Dermatol 160 2009 1075 1082
92. P. Joly, N. Bamberger, B. Crickx, and S. Belaich Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients Arch Dermatol 130 1994 663 664
93. A. Morita, K. Kobayashi, I. Isomura, T. Tsuji, and J. Krutmann Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis J Am Acad Dermatol 43 2000 670 674
94. M. El-Mofty, W. Mostafa, S. Esmat, R. Youssef, M. Bousseila, and N. Nagi Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study Photodermatol Photoimmunol Photomed 20 2004 93 100
95. M. Kerscher, T. Dirschka, and M. Volkenandt Treatment of localized scleroderma by UVA1 phototherapy Lancet 346 1995 1166
96. H. Stege, M. Berneburg, S. Humke, M. Klammer, M. Grewe, and S. Grether-Beck High-dose UVA1 radiation therapy for localized scleroderma J Am Acad Dermatol 36 1997 938 944
97. M. Kerscher, M. Volkenandt, C. Gruss, T. Reuther, G. von Kobyletzki, and M. Freitag Low-dose UVA phototherapy for treatment of localized scleroderma J Am Acad Dermatol 38 1998 21 26
98. C.J. Gruss, G. von Kobyletzky, S.C. Behrens-Williams, J. Lininger, T. Reuther, and M. Kerscher Effects of low dose ultraviolet A-1 phototherapy on morphea Photodermatol Photoimmunol Photomed 17 2001 149 155
99. M.A. De Rie, D.N. Enomoto, H.J. de Vries, and J.D. Bos Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method Dermatology 207 2003 298 301
100. P.G. Sator, S. Radakovic, K. Schulmeister, H. Hönigsmann, and A. Tanew Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment J Am Acad Dermatol 60 2009 786 791
101. C. Andres, A. Kollmar, M. Mempel, R. Hein, J. Ring, and B. Eberlein Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study Br J Dermatol 162 2010 445 447
102. A. Kreuter, T. Gambichler, A. Avermaete, T. Jansen, M. Hoffmann, and K. Hoffmann Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea Pediatr Dermatol 18 2011 241 245
103. A. Kreuter, and T. Gambichler UV-A1 phototherapy for sclerotic skin diseases: implications for optimizing patient selection and management Arch Dermatol 144 2008 912 916
104. F. Wang, L.A. Garza, S. Cho, R. Kafi, C. Hammerberg, and T. Quan Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototheraphy Arch Dermatol 144 2008 851 858
105. M. Kerscher, M. Meurer, C. Sander, M. Volkenandt, P. Lehmann, and G. Plewig PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients Arch Dermatol 132 1996 1280 1282
106. M. El-Mofty, W. Mostafa, M. El-Darouty, M. Bousseila, H. Nada, and R. Youssef Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis Photodermatol Photoimmunol Photomed 20 2004 148 156
107. N. Usmani, A. Murphy, D. Veale, V. Goulden, and M. Goodfield Photochemotherapy for localized morphea: effect on clinical and molecular markers Clin Exp Dermatol 33 2008 698 704
108. A. Kreuter, J. Hyun, M. Stücker, A. Sommer, P. Altmeyer, and T. Gambichler A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma J Am Acad Dermatol 54 2006 440 447
109. M.P. Crespo, I.B. Mas, J.M. Díaz, A.L. Costa, and I.B. Nortes Rapid response to cyclosporine and maintenance with methotrexate in linear scleroderma in a young girl Pediatr Dermatol 26 2009 118 120
110. J.H. Neustadter, F. Samarin, K.R. Carlson, and M. Girardi Extracorporeal photochemotherapy for generalized deep morphea Arch Dermatol 145 2009 127 130
111. M. Schlaak, H. Friedlein, F. Kauer, R. Renner, C. Rogalski, and J.C. Simon Successful therapy of a patient with therapy recalcitrant generalized bullous scleroderma by extracorporeal photopheresis and mycophenolate mofetil J Eur Acad Dermatol Venereol 22 2008 631 633
112. G. Martini, A.V. Ramanan, F. Falcini, H. Girschick, D.P. Goldsmith, and F. Zulian Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil Rheumatology (Oxford) 48 2009 1410 1413
113. C.T. Derk, E. Grace, M. Shenin, M. Naik, S. Schultz, and W. Xiong A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis Rheumatology (Oxford) 48 2009 1595 1599
114. M. Diab, J.R. Coloe, C. Magro, and M.A. Bechtel Treatment of recalcitrant generalized morphea with infliximab Arch Dermatol 146 2010 601 604
115. P. Moinzadeh, T. Krieg, and N. Hunzelmann Imatinib treatment of generalized localized scleroderma (morphea) J Am Acad Dermatol 63 2010 102 104
116. E.B. Kroft, T.J. Groeneveld, M.M. Seyger, and E.M. de Jong Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study Am J Clin Dermatol 10 2009 181 187
117. M. Dytoc, P.T. Ting, J. Man, D. Sawyer, and L. Fiorillo First case series on the use of imiquimod for morphoea Br J Dermatol 153 2005 815 820
118. E. Campione, E.J. Paternò, L. Diluvio, A. Orlandi, L. Bianchi, and S. Chimenti Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness J Dermatolog Treat 20 2009 10 13
119. M.T. Dytoc, I. Kossintseva, and P.T. Ting First case series on the use of calcipotriol-betamethasone dipropionate for morphoea Br J Dermatol 157 2007 615 618
120. R. Batchelor, S. Lamb, V. Goulden, G. Stables, M. Goodfield, and W. Merchant Photodynamic therapy for the treatment of morphoea Clin Exp Dermatol 33 2008 661 663
121. S. Saxton-Daniels, and H.T. Jacobe An evaluation of long-term outcomes in adults with pediatric-onset morphea Arch Dermatol 146 2010 1044 1045